On the other hand, high LIFR expression has been correlated with tumor progression, and inhibition of LIFR improves histone deacetylase (HDAC) inhibitor efficacy [67], suggesting that further research is needed to elucidate the role of LIF and LIFR in breast cancer. This evidence concerns the gene LIFR and breast carcinoma.